Optimizing Viral Vector Upstream Production: Key Strategies for Robust and Scalable rAAV Manufacturing
In clinical and commercial viral vector production, the robustness, scalability, and efficiency of upstream processes critically influence titer, product quality, and cost of goods (COGs). Leveraging proven project experience, CoJourney has developed core optimization strategies to accelerate process understanding, streamline lockdowns, and ensure successful scale-up. Risk-Forward Strategy for Process Scale-Up Early bottleneck identification: Develop robust scale-down models to proactively […]
